Shopping Cart
- Remove All
Your shopping cart is currently empty
JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase, exhibiting effective antiviral activity in HCV replicon cells with EC50s of 0.38 μM for genotype 1a H77 strain and 0.035 μM for genotype 1b Con1 strain.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $4,859 | 8-10 weeks | |
| 50 mg | $6,318 | 8-10 weeks | |
| 100 mg | $8,219 | 8-10 weeks |
| Description | JTK-853 is a novel, non-nucleoside inhibitor of Hepatitis C Virus (HCV) polymerase, exhibiting effective antiviral activity in HCV replicon cells with EC50s of 0.38 μM for genotype 1a H77 strain and 0.035 μM for genotype 1b Con1 strain. |
| Targets&IC50 | HCV 1a H77:(EC50)0.38 μM, HCV 1b Con1:0.035 μM |
| In vitro | JTK-853 inhibits the drug-resistant colony formation in the genotype 1a replicon cells, and the numbers of JTK-853-resistant colonies are much lower than those of GS-9190-resistant colonies for both genotypes. When JTK-853 is incubated with the replicon cells for 48 h, it shows antiviral activity against genotype 1a H77 and 1b Con1 replicon cells (EC90: 6.5±0.5 and 0.34±0.05 μM, respectively). In 2-week culture, JTK-853(at 10 μM) causes apparent Huh-7.5 cell death[1]. |
| Molecular Weight | 704.64 |
| Formula | C28H23F7N6O4S2 |
| Cas No. | 954389-09-4 |
| Relative Density. | 1.565 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.